Confirmed Activity and Tolerability of Weekly Paclitaxel in the Treatment of Advanced Angiosarcoma

Background. In several prospective and retrospective studies, weekly paclitaxel showed promising activity in patients with angiosarcoma. Patients and Methods. Our study was originally designed as a prospective, phase II multicenter trial for patients younger than 75, with ECOG performance status 0–2...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Sarcoma
Κύριοι συγγραφείς: Apice, Gaetano, Pizzolorusso, Antonio, Di Maio, Massimo, Grignani, Giovanni, Gebbia, Vittorio, Buonadonna, Angela, De Chiara, Annarosaria, Fazioli, Flavio, De Palma, Giampaolo, Galizia, Danilo, Arcara, Carlo, Mozzillo, Nicola, Perrone, Francesco
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Hindawi Publishing Corporation 2016
Θέματα:
Clinical Study
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4785388/
https://ncbi.nlm.nih.gov/pubmed/27019606
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/6862090
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια